Ekso Bionics Holdings, Inc. (LON: 0IFR)
London
· Delayed Price · Currency is GBP · Price in USD
0.606
-0.045 (-6.87%)
At close: Jan 21, 2025
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $4.13M USD in the quarter ending September 30, 2024, a decrease of -10.38%. This brings the company's revenue in the last twelve months to $17.68M, up 4.12% year-over-year. In the year 2023, Ekso Bionics Holdings had annual revenue of $18.28M with 41.57% growth.
Revenue (ttm)
$17.68M
Revenue Growth
+4.12%
P/S Ratio
n/a
Revenue / Employee
$245.58K
Employees
72
Market Cap
11.48M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.28M | 5.37M | 41.57% |
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | 13.92M | 2.59M | 22.81% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 221.41B |
AstraZeneca | 38.20B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |